Affimed NV (NASDAQ:AFMD)
| 9.64 Delayed Data As of 3:59pm ET |  -0.09 / -0.92%Today’s Change | 1.88 Today|||52-Week Range 10.70 | +65.64% Year-to-Date |
Latest AFMD News | Press Releases
| Company News for Apr 12, 2021 9:37am / Zacks.com - Paid Partner Content | Here's Why Shares of Affimed Skyrocketed Today Apr 09 / MotleyFool.com - Paid Partner Content |
| Affimed NV Stock Appears To Be Significantly Overvalued Apr 11 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 9.73 |
| Today’s open | 10.11 |
| Day’s range | 9.28 - 10.11 |
| Volume | 235,061 |
| Average volume (3 months) | 2,724,749 |
| Market cap | $1.0B |
Data as of 3:59pm ET, 04/12/2021
Growth & Valuation
| Earnings growth (last year) | -48.51% |
| Earnings growth (this year) | +36.52% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -14.50% |
| P/E ratio | NM |
| Price/Sales | 7.35 |
| Price/Book | 17.09 |
Competitors
Data as of 3:59pm ET, 04/12/2021
Financials
| Next reporting date | April 15, 2021 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $23.9M |
| Annual profit (last year) | -$36.2M |
| Net profit margin | -151.30% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Heidelberg, Baden Wuerttemberg |
Forecasts
